Wegovy
-
{
- All
- News
-
Ozempic And Wegovy Weight Loss Eventually Plateaus, Study Explains Why
While semaglutide has shown impressive results in aiding weight loss, many users may experience a plateau after an initial period of significant weight loss.
-
Popular Weight Loss Drug Wegovy Linked To Rare Blinding Eye Condition, Finds Study
The study does not say that Wegovy directly causes blindness. Instead, researchers found a strong link between the drug and a condition called ischemic optic neuropathy.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
From Diabetes To Weight Loss: How Semaglutide Became The Blockbuster Behind Ozempic, Wegovy
From a diabetes drug to a global weight-loss phenomenon, semaglutide has reshaped modern medicine. As patents expire, cheaper versions may expand access, raising questions about affordability, safety and long-term impact.
-
Wegovy Users Have 5x Higher Vision Loss Risk Than Ozempic, New Study Finds
A new study found that users of Wegovy have nearly five times the risk of ischemic optic neuropathy (ION), compared to Ozempic users. ION, also known as 'eye stroke', is a condition that happens due to reduced blood flow to the optic nerve.
-
Weight Loss Pill Wegovy Now Available On Amazon Pharmacy In The U.S.
Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical therapy from consumer health products.
-
"Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research
GLP-1 medications, Ozempic and Wegovy, may disrupt cancer imaging and its diagnosis, new research has revealed.
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
Novo Nordisk Launches Weight-Loss Drug 'Wegovy' In India
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy as a once-a-week injection in India.
-
Nature's Ozempic: What And How You Eat Affects Your Weight Loss Journey
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications.
-
Ozempic's Impact On Brain Chemistry May Influence Depression Risk: Study
Research suggests a potential link between popular weight loss drugs and brain changes that may lead to depression, highlighting the need for further investigation into their impact on mental health.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Ozempic And Wegovy Weight Loss Eventually Plateaus, Study Explains Why
While semaglutide has shown impressive results in aiding weight loss, many users may experience a plateau after an initial period of significant weight loss.
-
Popular Weight Loss Drug Wegovy Linked To Rare Blinding Eye Condition, Finds Study
The study does not say that Wegovy directly causes blindness. Instead, researchers found a strong link between the drug and a condition called ischemic optic neuropathy.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
From Diabetes To Weight Loss: How Semaglutide Became The Blockbuster Behind Ozempic, Wegovy
From a diabetes drug to a global weight-loss phenomenon, semaglutide has reshaped modern medicine. As patents expire, cheaper versions may expand access, raising questions about affordability, safety and long-term impact.
-
Wegovy Users Have 5x Higher Vision Loss Risk Than Ozempic, New Study Finds
A new study found that users of Wegovy have nearly five times the risk of ischemic optic neuropathy (ION), compared to Ozempic users. ION, also known as 'eye stroke', is a condition that happens due to reduced blood flow to the optic nerve.
-
Weight Loss Pill Wegovy Now Available On Amazon Pharmacy In The U.S.
Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical therapy from consumer health products.
-
"Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research
GLP-1 medications, Ozempic and Wegovy, may disrupt cancer imaging and its diagnosis, new research has revealed.
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
Novo Nordisk Launches Weight-Loss Drug 'Wegovy' In India
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy as a once-a-week injection in India.
-
Nature's Ozempic: What And How You Eat Affects Your Weight Loss Journey
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications.
-
Ozempic's Impact On Brain Chemistry May Influence Depression Risk: Study
Research suggests a potential link between popular weight loss drugs and brain changes that may lead to depression, highlighting the need for further investigation into their impact on mental health.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
